Trial intelligence / Profile preview

Psilocybin and 'Set and Setting' in Healthy Volunteers

NCT06626139Phase 2Recruiting

Start
Oct 2024
Primary completion
Nov 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of psilocybin in psychological well-being (4 arms). Primary endpoints: Challenging Experience Questionnaire, Warwick-Edinburgh Mental Wellbeing Scale and 2 more. Started Oct 2024; status: recruiting.

02

Drugs

psilocybin
03

Conditions

psychological well-being

Beyond the preview

Go deeper on NCT06626139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06626139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call